These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9456681)

  • 1. Epstein-Barr virus: biology and disease.
    Cruchley AT; Williams DM; Niedobitek G; Young LS
    Oral Dis; 1997 May; 3 Suppl 1():S156-63. PubMed ID: 9456681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of the Epstein-Barr virus nuclear antigen (EBNA-I) in oral hairy leukoplakia.
    Cruchley AT; Murray PG; Niedobitek G; Reynolds GM; Williams DM; Young LS
    Oral Dis; 1997 May; 3 Suppl 1():S177-9. PubMed ID: 9456684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of expression of HHV8, EBV and HPV in selected HIV-associated oral lesions.
    Hille JJ; Webster-Cyriaque J; Palefski JM; Raab-Traub N
    Oral Dis; 2002; 8 Suppl 2():161-8. PubMed ID: 12164651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus infection and expression in oral lesions.
    Raab-Traub N; Webster-Cyriaque J
    Oral Dis; 1997 May; 3 Suppl 1():S164-70. PubMed ID: 9456682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
    Longnecker R
    Adv Cancer Res; 2000; 79():175-200. PubMed ID: 10818681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase.
    Niedobitek G; Young LS; Lau R; Brooks L; Greenspan D; Greenspan JS; Rickinson AB
    J Gen Virol; 1991 Dec; 72 ( Pt 12)():3035-46. PubMed ID: 1662695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphomas of the oral soft tissues are not preferentially associated with latent or replicative Epstein-Barr virus.
    Gulley ML; Sargeant KP; Grider DJ; Eagan PA; Davey DD; Damm DD; Robinson RA; Vandersteen DP; McGuff HS; Banks PM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Oct; 80(4):425-31. PubMed ID: 8521106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus and oncogenesis: from latent genes to tumours.
    Young LS; Murray PG
    Oncogene; 2003 Aug; 22(33):5108-21. PubMed ID: 12910248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus BMRF-2 and BDLF-3 expression in hairy leukoplakia.
    Palefsky JM; Peñaranda ME; Pierik LT; Lagenaur LA; MacPhail LA; Greenspan D; Greenspan JS
    Oral Dis; 1997 May; 3 Suppl 1():S171-6. PubMed ID: 9456683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
    Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
    J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Epstein-Barr virus genome and latent infection gene expression in normal epithelia, epithelial dysplasia, and squamous cell carcinoma of the oral cavity.
    Kikuchi K; Noguchi Y; de Rivera MW; Hoshino M; Sakashita H; Yamada T; Inoue H; Miyazaki Y; Nozaki T; González-López BS; Ide F; Kusama K
    Tumour Biol; 2016 Mar; 37(3):3389-404. PubMed ID: 26449822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence and transition of Epstein-Barr virus genotypes in the pathogenesis of oral hairy leukoplakia.
    Walling DM; Etienne W; Ray AJ; Flaitz CM; Nichols CM
    J Infect Dis; 2004 Jul; 190(2):387-95. PubMed ID: 15216477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Epstein-Barr virus latent genes in oral epithelium: determinants of the pathogenesis of oral hairy leukoplakia.
    Walling DM; Ling PD; Gordadze AV; Montes-Walters M; Flaitz CM; Nichols CM
    J Infect Dis; 2004 Jul; 190(2):396-9. PubMed ID: 15216478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular localization of the Epstein-Barr virus BFRF1 gene product in lymphoid cell lines and oral hairy leukoplakia lesions.
    Farina A; Cardinali G; Santarelli R; Gonnella R; Webster-Cyriaque J; Bei R; Muraro R; Frati L; Angeloni A; Torrisi MR; Faggioni A
    J Med Virol; 2004 Jan; 72(1):102-11. PubMed ID: 14635017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas.
    Murray PG; Niedobitek G; Kremmer E; Grässer F; Reynolds GM; Cruchley A; Williams DM; Müller-Lantzsch N; Young LS
    J Pathol; 1996 Jan; 178(1):44-7. PubMed ID: 8778314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies.
    Gutierrez MI; Bhatia K; Magrath I
    Leuk Res; 1993 Mar; 17(3):285-9. PubMed ID: 8383779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections.
    Webster-Cyriaque J; Middeldorp J; Raab-Traub N
    J Virol; 2000 Aug; 74(16):7610-8. PubMed ID: 10906215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral EBV and KSHV infection in HIV.
    Webster-Cyriaque J; Duus K; Cooper C; Duncan M
    Adv Dent Res; 2006 Apr; 19(1):91-5. PubMed ID: 16672557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo.
    Walling DM; Flaitz CM; Nichols CM; Hudnall SD; Adler-Storthz K
    J Infect Dis; 2001 Dec; 184(12):1499-507. PubMed ID: 11740724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.